Concise Review: Bridging the Gap: Novel Neuroregenerative and Neuroprotective Strategies in Spinal Cord Injury.
Study Goal
The researchers discussed the role of chondroitin sulfate proteoglycans in forming inhibitory glial scars post-spinal cord injury and explored potential neuroregenerative strategies, including glial scar degradation.
Results Summary
The abstract mentions that chondroitin sulfate proteoglycans contribute to the formation of an inhibitory glial scar, which impedes long-term regeneration after spinal cord injury. Potential strategies like glial scar degradation were highlighted as key neuroregenerative approaches for future research.
Population
Patients with spinal cord injuries.
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
surgical decompression | neutral | neuroprotection | patients with spinal cord injuries | - | important neuroprotective interventions currently applied in clinical practice | #1 |
blood pressure augmentation | neutral | neuroprotection | patients with spinal cord injuries | - | important neuroprotective interventions currently applied in clinical practice | #2 |
i.v. methylprednisolone | neutral | neuroprotection | patients with spinal cord injuries | - | important neuroprotective interventions currently applied in clinical practice | #3 |
riluzole | neutral | neuroprotection | patients with spinal cord injuries | - | exciting translational therapies on the horizon | #4 |
minocycline | neutral | neuroprotection | patients with spinal cord injuries | - | exciting translational therapies on the horizon | #5 |
fibroblast growth factor | neutral | neuroprotection | patients with spinal cord injuries | - | exciting translational therapies on the horizon | #6 |
magnesium | neutral | neuroprotection | patients with spinal cord injuries | - | exciting translational therapies on the horizon | #7 |
hypothermia | neutral | neuroprotection | patients with spinal cord injuries | - | exciting translational therapies on the horizon | #8 |
glial scar degradation | neutral | neuroregeneration | patients with spinal cord injuries | - | key neuroregenerative strategies of the next decade | #9 |
Rho-ROCK inhibition | neutral | neuroregeneration | patients with spinal cord injuries | - | key neuroregenerative strategies of the next decade | #10 |
cell-based therapies | neutral | neuroregeneration | patients with spinal cord injuries | - | key neuroregenerative strategies of the next decade | #11 |
novel bioengineered adjuncts | neutral | neuroregeneration | patients with spinal cord injuries | - | key neuroregenerative strategies of the next decade | #12 |
UNLABELLED: Spinal cord injuries (SCIs) result in devastating lifelong disability for patients and their families. The initial mechanical trauma is followed by a damaging secondary injury cascade involving proapoptotic signaling, ischemia, and inflammatory cell infiltration. Ongoing cellular necrosis releases ATP, DNA, glutamate, and free radicals to create a cytotoxic postinjury milieu. Long-term regeneration of lost or injured networks is further impeded by cystic cavitation and the formation of an inhibitory glial-chondroitin sulfate proteoglycan scar. In this article, we discuss important neuroprotective interventions currently applied in clinical practice, including surgical decompression, blood pressure augmentation, and i.v. methylprednisolone. We then explore exciting translational therapies on the horizon, such as riluzole, minocycline, fibroblast growth factor, magnesium, and hypothermia. Finally, we summarize the key neuroregenerative strategies of the next decade, including glial scar degradation, Rho-ROCK inhibition, cell-based therapies, and novel bioengineered adjuncts. Throughout, we emphasize the need for combinatorial approaches to this multifactorial problem and discuss relevant studies at the forefront of translation. We conclude by providing our perspectives on the future direction of SCI research. SIGNIFICANCE: Spinal cord injuries (SCIs) result in devastating, lifelong disability for patients and their families. This article discusses important neuroprotective interventions currently applied in clinical practice, including surgical decompression, blood pressure augmentation, and i.v. methylprednisolone. Translational therapies on the horizon are discussed, such as riluzole, minocycline, fibroblast growth factor, magnesium, and hypothermia. The key neuroregenerative strategies of the next decade are summarized, including glial scar degradation, Rho-ROCK inhibition, cell-based therapies, and novel bioengineered adjuncts. The need for combinatorial approaches to this multifactorial problem is emphasized, relevant studies at the forefront of translation are discussed, and perspectives on the future direction of SCI research are presented.